Example: Heart Attack

Search clinical trials for: Adjuvants, Immunologic

Total 2298 results

NCT01997814

Completed

Role of Herbal Immunomodulators in the Treatment of Chronic Periodontitis

Conditions: Chronic Periodontitis
NCT03392545

Recruiting

Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)

Conditions: High Grade Glioma; Glioblastoma; Glioma of Brainstem; Glioma, Malignant
NCT01141491

Completed

Trivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease Free

Conditions: Sarcoma
NCT01208194

Completed

Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma

Conditions: Advanced Colorectal Carcinoma
NCT01065727

Unknown status

Impact Study of 2 Therapeutic Strategy for Aggressive Remitting Multiple Sclerosis

Conditions: Multiple Sclerosis
NCT01081223

Completed

Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

Conditions: Glioma; High Grade Astrocytoma; Glioblastoma Multiforme
NCT01248273

Completed

Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

Conditions: Fallopian Tubes; Ovarian Cancer; Peritoneal Cancer
NCT04352335

Completed

Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator

Conditions: Advanced Lung Cancer
NCT01802593

Terminated

Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure

Conditions: Crohn's Disease
NCT02413047

Terminated

Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator

Conditions: Inflammatory Bowel Disease; Ulcerative Colitis; Crohn's Disease
NCT00857545

Completed

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

Conditions: Stage IA Fallopian Tube Cancer; Stage IA Ovarian Cancer; Stage IB Fallopian Tube Cancer; Stage IB Ovarian Cancer; Stage IC Fallopian Tube Cancer; Stage IC Ovarian Cancer; Stage IIA Fallopian Tube Cancer; Stage IIA Ovarian Cancer; Stage IIB Fallopian Tube Cancer; Stage IIB Ovarian Cancer; Stage IIC Fallopian Tube Cancer; Stage IIC Ovarian Cancer; Stage IIIA Fallopian Tube Cancer; Stage IIIA Ovarian Cancer; Stage IIIA Primary Peritoneal Cancer; Stage IIIB Fallopian Tube Cancer; Stage IIIB Ovarian Cancer; Stage IIIB Primary Peritoneal Cancer; Stage IIIC Fallopian Tube Cancer; Stage IIIC Ovarian Cancer; Stage IIIC Primary Peritoneal Cancer; Stage IV Fallopian Tube Cancer; Stage IV Ovarian Cancer; Stage IV Primary Peritoneal Cancer
NCT00693342

Withdrawn

Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission

Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
NCT02013323

Completed

Clinical and Microbiological Efficacy of Systemic Ayurvedic Immunomodulator Septilin in the Treatment of Chronic Periodontitis

Conditions: Chronic Periodontitis
NCT01222338

Completed

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Conditions: Tuberculosis
NCT01290692

Completed

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

Conditions: Grade IV Glioma; Grade IV Astrocytoma; Glioblastoma Multiforme
NCT04542447

Recruiting

To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.

Conditions: Covid19
NCT00803907

Unknown status

Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma

Conditions: Carcinoma, Basal Cell
NCT00365937

Terminated

Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides

Conditions: Melanoma
NCT00341328

Completed

Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.

Conditions: Tuberculosis
NCT00705835

Completed

Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel

Conditions: Prostate Cancer
NCT00265226

Completed

Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients

Conditions: Tuberculosis
NCT02804581

Unknown status

Gum Arabic as Immunomodulator In Rheumatoid Arthritis Patients

Conditions: Rheumatoid Arthritis
NCT03312244

Suspended

Pyridostigmine as Immunomodulator in People Living With HIV

Conditions: HIV-1-infection; CD4+ T Lymphocytopenia; Immune Deficiency; Immuno-senescence
NCT04389931

Completed

Effect of Omega 3 as an Immunomodulator Adjunct to Periodontal Debridement

Conditions: Periodontitis
NCT01924169

Terminated

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

Conditions: Hematologic Disorder